About this event
Molecular analysis is revolutionizing precision oncology, driving breakthroughs in early detection and tailored treatments. However, challenges like rising costs, clinical trial limitations and data integration must be overcome to ensure equitable care.
This unique webinar series showcases cutting-edge advances in diagnostics, molecular profiling and therapy resistance, revealing how adaptive strategies are reshaping cancer treatment.
Mark your calendar for Thursday 10th, 17th and 24th April 2025 at 3pm BST / 4pm CET / 10am ET.
By attending this webinar series, you will:
**Please note, that by registering for the first webinar in the series, you will automatically gain access to the subsequent webinars**
Thursday 10th April 2025 at 3pm BST / 4pm CET / 10am ET
This webinar will explore advanced diagnostic tools that enable earlier and more accurate identification of biomarkers, guiding personalized treatment strategies.
Attendees will gain insights into how these technologies inform therapeutic decisions, optimize treatment selection, and improve patient outcomes. The session will highlight how these innovations are shaping oncology's future by advancing precision diagnostics and tailored treatment management.
Talk 1: Implementing ctDNA in the NHS for Treatment Decision Making - Sanjay Popat, Consultant Medical Oncologist, The Royal Marsden, Professor of Thoracic Oncology, the Institute of Cancer Research
Talk 2: Cancer Diagnostics in Solid Tumors: From Pathology to Precision Oncology - Umberto Malapelle, Associate Professor, Department of Public Health, University of Naples "Federico II"
Talk 3: Using ctDNA Assays to Influence Clinical Decision Making in Colorectal Cancer - Eric Christenson, Assistant Professor of Oncology, Johns Hopkins
Thursday, 17th April 2025 at 3pm BST / 4pm CET / 10am ET
This webinar is designed to help you gain insights into how molecular profiling technologies are enhancing our understanding of tumor biology, guiding personalized treatment strategies and improving treatment efficacy. The session will also highlight how these innovations are enabling clinicians to make more informed decisions, ultimately leading to better patient outcomes through more targeted and effective therapies.
Talk 1: Integrating Epigenomics and Functional Genomics Identifies EP300 as a Therapeutic Vulnerability in High-Risk Pediatric Cancers - Adam Durbin, Principal Investigator and Assistant Member, St. Jude Children's Research Hospital
Talk 2: Comprehensive Genomic Profiling: The Current and Future Needs in Molecular Diagnostic Pathology - Ed Schuuring, Professor of Molecular Oncological Pathology, UMCG
Talk 3: Spatial Insights into Immune Hedgehog Signaling: Mechanisms and Therapeutic Potential in Cancer - Maike de la Roche, Group Leader, CRUK Cambridge Institute, University of Cambridge
Thursday, 24th April 2025 at 3pm BST / 4pm CET / 10am ET
Therapeutic resistance continues to be one of the most significant challenges in oncology, but recent advancements in molecular analysis are paving the way for innovative strategies to address this issue. This webinar will examine the persistent problem of therapeutic resistance in cancer treatment and highlight how breakthroughs are opening new avenues to combat it. Key takeaways will include insights into the role of molecular profiling in identifying resistance markers and the potential of combination therapies.
Talk 1: Targeting the Metabolic Vulnerability in an Emerging Molecular Subtype of Castration-resistant Prostate Cancer - Di Zhao, Assistant Professor, Experimental Radiation Oncology, UT MD Anderson Cancer Center
Talk 2: Harnessing Disease Resilience: Gene Editing and Targeted Modulation of Tumor-Immune Interactions - Winston Hide, Director of the Precision RNA Medicine Core, Beth Israel Deaconess Medical Center
Talk 3: Myeloid Populations as Drivers of Spatially Confined T Cell Exhaustion Following Ovarian Cancer Chemotherapy - Anna Vähärautio, PI, Research Program in Systems Oncology, University of Helsinki
Hosted by
Front Line Genomics is a genomics-focused media company, with a social mission to deliver the benefits of genomics to patients faster. We organise the Festival of Genomics, digital events and webinars. We also produce reports and operate a content-rich website.
